The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.

Companies / V•••••••• T•••••••••

V•••••••• T•••••••••

Series AUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$54.0Msum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. Apr 10, 2026
    Series A · $54.0M (disclosed)
    Q••••• V•••••• P••••••• (lead)H•••••••• C•••••• (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “V•••••••• T••••••••• Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA T••••••••• Development”
Investors on record
2 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Apr 10, 2026
    V•••••••• T••••••••• announced Series A of $54,000,000, led by Q••••• V•••••• P•••••••
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company